Stonehage Fleming (UK)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-927	Closed	-$36K	–	328
2014 Q2	$36K	Sell	927 -610	-40%	-$23.7K	0.01%	185
2014 Q1	$64K	Sell	1,537 -217	-12%	-$9.04K	0.03%	222
2013 Q4	$58K	Buy	+1,754	New	+$58K	0.02%	210